Society of Thoracic Surgeons - Congenital

JANUARY 25, 2025

Hunter Mehaffey, MD, a cardiothoracic surgeon from West Virginia University, will examine results comparing two treatment options Transcatheter vs. Surgical Aortic Valve Replacement in Medicare Beneficiaries with Aortic Stenosis and Significant Coronary Disease.

Medicare 52

Medicare Coronary Artery Disease Stenosis Aortic 52

DAIC

MARCH 14, 2025

Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE): Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation (..)

TAVR 52

TAVR Aortic valve Peripheral Arterial Disease Embolism 52

DAIC

MARCH 10, 2025

Yasser Sammour, MD, MScpresented "Long-Term Hemodynamic Performance and Clinical Outcomes in Small and Large Aortic Annuli Patients with Severe Aortic Stenosis."This Safety outcomes, including the presence of renal artery stenosis greater than 70%, were also evaluated. This study is a pooled analysis from the U.S.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

DAIC

MAY 8, 2024

6 This novel study marks a significant milestone in the field, evaluating the effectiveness of FFR CT in detecting ischemia-producing coronary stenosis in patients with severe PAD. Longitudinal assessment of safety of FEMOROPOPLITEAL endovascular treatment with paclitaxel-coated devices among Medicare beneficiaries.” 1071, [link].

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

JUNE 18, 2024

We look forward to working with FDA, Centers for Medicare & Medicaid Services, and respective physician societies to bring this technology t­­o U.S. 3 “We very much appreciate FDA’s breakthrough designation recognition of the bioadaptor technology,” continued Sirhan. “We vs. 8.7%; p=0.028) in the TLF rate with DynamX bioadaptor versus DES.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stent Stents 105

DAIC

MARCH 10, 2025

Yasser Sammour, MD, MScpresented "Long-Term Hemodynamic Performance and Clinical Outcomes in Small and Large Aortic Annuli Patients with Severe Aortic Stenosis."This Safety outcomes, including the presence of renal artery stenosis greater than 70%, were also evaluated. This study is a pooled analysis from the U.S.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

Dr. Anish Koka

JULY 23, 2023

Jeffery Dormu was a double board certified vascular surgeon who was paid $13 million dollars by Medicare alone between 2013 and 2017. In 2018, he even opened a state of the art lab nicknamed “the Watcher” and was paid $18 million from Medicare in the next 3 years. 4.1.2017.

Vascular Care 52

Vascular Care Outpatient Peripheral Arterial Disease Stent 52